The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kolesnikov V.N.

Rostov State Medical University

Khanamirov A.A.

Rostov Regional Clinical Hospital

Boiko N.V.

Rostov State Medical University

Lapin M.A.

Rostov Regional Clinical Hospital

Stagniev S.D.

Rostov State Medical University

Postcovid sino-orbital mucormycosis: a case report

Authors:

Kolesnikov V.N., Khanamirov A.A., Boiko N.V., Lapin M.A., Stagniev S.D.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2022;87(3): 107‑111

Read: 2311 times


To cite this article:

Kolesnikov VN, Khanamirov AA, Boiko NV, Lapin MA, Stagniev SD. Postcovid sino-orbital mucormycosis: a case report. Russian Bulletin of Otorhinolaryngology. 2022;87(3):107‑111. (In Russ.)
https://doi.org/10.17116/otorino202287031107

Recommended articles:
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Diffuse changes in the brain in the acute phase of COVID-19 and after infe­ction. Russian Journal of Archive of Pathology. 2025;(1):5-15
Liver pathology in COVID-19. Russian Journal of Archive of Pathology. 2025;(1):53-59

References:

  1. Dilek A, Ozaras R, Ozraya S, Sunbul M, Sen ET, Leblebicioglu H. COVID-19-associated mucormycosis: Case report and systematic review. Travel Medicine and Infectious Disease. 2021;44:102148. https://doi.org/10.1016/j.tmaid.2021.102148
  2. Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. The Journal of Laryngology and Otology. 2021; 135(5):1-6.  https://doi.org/10.1017/S0022215121000992
  3. Kubin CJ, McConville Thomas H, Donald D, Zucker J, May M, Nelson B, Istorico E, Bartram L, Small-Saunders J, Sobieszczyk ME, Gomez-Simmonds A, Uhlemann A-C. Characterization of bacterial and fungal infections in hospitalized patients with COVID-19 and factors associated with healthcare-associated infections. Open Forum Infectious Diseases. 2021;8(6):ofab201. https://doi.org/10.1093/ofid/ofab201
  4. Hussain S, Baxi H, Riad A, Klugarova J, Pokorna A, Slezakova S, Lictnik R, Najmi AK, Klugar M. COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping. International Journal of Environmental Research and Public Health. 2021;18(19):10340. https://doi.org/10.3390/ijerph181910340
  5. Boiko NV. Caseous rhinosinusitis: fungal or bacterial ball? An International Journal of Otorhinolaryngology Clinics. 2019;11(3):64-66.  https://doi.org/10.5005/jp/journals-10003-1342
  6. Boiko NV, Mironov VG, Bannikov SA. Differential diagnostics of noninvasive mycosis of paranasal sinuses: fungal or bacterial ball? Meditsinskij vestnik Severnogo Kavkaza. 2019;14(2):330-333. (In Russ.). https://doi.org/10.14300/mnnc.2019.14080
  7. Karpishchenko SA, Dolgov OI, Rodneva YuA, Zubareva AA, Moiseev IS, Zubarovskaya LS, Kozhokar PV, Paina OV, Ekushov KA, Pinegina ON, Khalilova KA. Experience of the surgical treatment of polysinusitis caused by mucormycosis in a child with acute leukemia before allogeneic bone marrow transplantation. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2021;27(2):80-88. (In Russ.). https://doi.org/10.33848/foliorl23103825-2021-27-2-80-88
  8. Choudhary NK, Jain AK, Soni R, Gehlot N. Mucormycosis: A deadly black fungus infection among COVID-19 patients in India. Clinical Epidemiology and Global Health. 2021;12:100900. https://doi.org/10.1016/j.cegh.2021.100900
  9. Pushparaj K, Bhotla HK, Arumugam VA, Pappusamy M, Easwaran M, Liu W-C, Issara U, Rengasamy KRR, Meyyazhagan A, Balasubramanian B. Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets — Magnifying global pandemic grieve and catastrophe begins. The Science of the Total Environment. 2022;805:150355. https://doi.org/10.1016/j.scitotenv.2021.150355
  10. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel C-P, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee D-L, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJ, Walsh TJ, White LP, Wiederhold NP, Zaoutis T, Chakrabarti A. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet. Infectious Diseases. 2019;19(12):405-421.  https://doi.org/10.1016/S1473-3099(19)30312-3
  11. Kumari A, Rao NP, Patnaik U, Malik V, Tevatia MS, Thakur S, Jaydevan J, Saxena P. Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital. Medical Journal, Armed Forces India. 2021;77(Suppl 2): 289-295.  https://doi.org/10.1016/j.mjafi.2021.06.009

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.